XTX Topco’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Sell
169,397
-116,383
-41% -$320K 0.01% 2155
2026
Q1
$383K Buy
285,780
+212,338
+289% +$423K 0.01% 2272
2025
Q4
$180K Buy
+73,442
New +$319K ﹤0.01% 2446
2025
Q2
Sell
-10,487
Closed -$88K 3167
2025
Q1
$88K Buy
+10,487
New +$94.3K ﹤0.01% 1896
2024
Q3
Sell
-24,104
Closed -$160K 2616
2024
Q2
$160K Buy
+24,104
New +$195K 0.01% 1314
2023
Q4
Sell
-10,174
Closed -$133K 2150
2023
Q3
$133K Buy
+10,174
New +$186K 0.02% 1136
2023
Q2
Sell
-10,511
Closed -$265K 1845
2023
Q1
$265K Buy
+10,511
New +$247K 0.06% 753

Other funds holding TMCI

XTX Topco's TMCI Position: Q2 2026 in Review

XTX Topco reduced its Treace Medical Concepts (TMCI) stake by 41% in Q2 2026, selling an estimated $320K and leaving 169,397 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #2155.

XTX Topco first reported a position in TMCI in Q1 2023 and has held it in 7 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • XTX Topco held 169,397 shares of Treace Medical Concepts worth $674K as of Q2 2026.
  • XTX Topco sold 116,383 Treace Medical Concepts shares in Q2 2026, an estimated $320K.
  • Treace Medical Concepts made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2155 holding.
  • XTX Topco first reported a position in Treace Medical Concepts in Q1 2023 and has held it in 7 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.